- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04995549
SKin Uncertainties Modeling (SKUM)
March 20, 2023 updated by: Centre Hospitalier Universitaire de Besancon
Construction of a Mechanical Data Base for Mathematically Modeling Uncertainties in Human Skin Tissues
The study is based on measurement device and will provide a database of viscoelastic properties of the forearm skin among healthy volunteers.
These data will be used to develop a mathematical model representative of the mechanical behavior of the skin.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Besançon, France, 25030
- CHU de Besançon
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy volunteers aged 18 to 50 years old
- non-opposition to participating in SKUM study
- Affiliation to french social security
Exclusion Criteria:
- Refusal to participate
- Volunteer with any skin disease likely to interfere with the primary outcome
- Legal incapacity or limited legal capacity
- Subject unlikely to cooperate with the study and / or weak cooperation
- Subject without health insurance
- Pregnant woman
- Subject being in the period of exclusion from another study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Measures using Cutiscan® CS 100
|
Repeated measures on healthy volunteers skin (forearm) are performed using Cutiscan® CS 100 device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Height of displacement (mm) of a skin disc.
Time Frame: Month 1
|
The displacement will be obtained from repeated measures, on 30 volunteers, on forearm skin, and using Cutiscan® CS100 device.
A database of skin viscoelasticity measure will be built from such data.
|
Month 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Brice CHATELAIN, MD, CHU de Besançon
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 26, 2021
Primary Completion (Actual)
January 19, 2022
Study Completion (Actual)
February 22, 2022
Study Registration Dates
First Submitted
May 19, 2021
First Submitted That Met QC Criteria
July 29, 2021
First Posted (Actual)
August 9, 2021
Study Record Updates
Last Update Posted (Actual)
March 21, 2023
Last Update Submitted That Met QC Criteria
March 20, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2020/527
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Unrecognized Condition
-
Kaohsiung Veterans General Hospital.Recruiting
-
Kaohsiung Veterans General Hospital.Terminated
-
Kaohsiung Veterans General Hospital.Active, not recruitingUnrecognized ConditionTaiwan
-
Samsung Medical CenterSamsung Semiconductor R&D centerCompletedUnrecognized ConditionKorea, Republic of
-
General Hospital of Chinese Armed Police ForcesCompleted
-
Queen Savang Vadhana Memorial Hospital, ThailandRecruitingUnrecognized ConditionThailand
-
Artvin Coruh UniversityCompletedUnrecognized ConditionTurkey
-
Sultan Abdulhamid Han Training and Research Hospital...CompletedUnrecognized ConditionTurkey
-
Bnai Zion Medical CenterNot yet recruiting
-
Kaohsiung Veterans General Hospital.Recruiting
Clinical Trials on Cutiscan® CS 100
-
MicroPort Orthopedics Inc.Active, not recruitingJoint DiseaseCanada, United States, Belgium, Germany, United Kingdom
-
MicroPort Orthopedics Inc.Recruiting
-
co.don AGCompletedLarge Articular Cartilage Lesions of the Femoral | Condyle, Trochlea, Tibia or RetropatellarGermany
-
co.don AGCompletedArticular Cartilage Lesion of the Femoral CondyleGermany, Poland
-
Spokane Joint Replacement CenterCompletedOsteoarthritis, KneeUnited States
-
Beni-Suef UniversityRecruitingAsthmatic Patients | Aerosol Generating Procedure | MDIEgypt
-
ExThera Medical CorporationWithdrawn
-
Tampere University HospitalTerminated
-
Children's Hospital Medical Center, CincinnatiExThera Medical CorporationCompletedCOVID-19 | SARS-CoV 2United States
-
Paragon Vision SciencesTigerMedRecruiting